AKT signaling as a novel factor associated with in vitro resistance of human AML to gemtuzumab ozogamicin.

por David B Rosen, Kimberly H Harrington, James A Cordeiro, Ling Y Leung, Santosh Putta, Norman Lacayo, George S Laszlo, Chelsea J Gudgeon, Donna E Hogge, Rachael E Hawtin, Alessandra Cesano, Roland B Walter
Publicado 2013